1. Home
  2. Labeler Index
  3. Padagis Us Llc
  4. 0574-0930
  5. NDC Package Code: 0574-0930-10 Doxorubicin Hydrochloride

NDC Package 0574-0930-10 Doxorubicin Hydrochloride

Injection, Suspension, Liposomal Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0574-0930-10
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-USE
Product Code:
0574-0930
Proprietary Name:
Doxorubicin Hydrochloride
Non-Proprietary Name:
Doxorubicin Hydrochloride
Substance Name:
Doxorubicin Hydrochloride
Usage Information:
Doxorubicin hydrochloride liposome injection is contraindicated in patients who have a history of severe hypersensitivity reactions, including anaphylaxis, to doxorubicin hydrochloride [see Warnings and Precautions (5.2)].
11-Digit NDC Billing Format:
00574093010
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1790115 - DOXOrubicin HCl liposome 20 MG in 10 ML Injection
  • RxCUI: 1790115 - 10 ML doxorubicin hydrochloride liposome 2 MG/ML Injection
  • RxCUI: 1790115 - doxorubicin hydrochloride liposome 20 MG per 10 ML Injection
  • RxCUI: 1790127 - DOXOrubicin HCl liposome 50 MG in 25 ML Injection
  • RxCUI: 1790127 - 25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Padagis Us Llc
    Dosage Form:
    Injection, Suspension, Liposomal - A liquid preparation, suitable for injection, which consists of an oil phase dispersed throughout an aqueous phase in such a manner that liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) are formed.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • DOXORUBICIN HYDROCHLORIDE 2 mg/mL
    • Pharmacologic Class(es):
  • Anthracycline Topoisomerase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Anthracyclines - [CS]
  • Topoisomerase Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA207228
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-25-2021
    End Marketing Date:
    04-30-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0574-0930-10?

    The NDC Packaged Code 0574-0930-10 is assigned to a package of 1 vial, single-use in 1 carton / 10 ml in 1 vial, single-use of Doxorubicin Hydrochloride, a human prescription drug labeled by Padagis Us Llc. The product's dosage form is injection, suspension, liposomal and is administered via intravenous form.

    Is NDC 0574-0930 included in the NDC Directory?

    Yes, Doxorubicin Hydrochloride with product code 0574-0930 is active and included in the NDC Directory. The product was first marketed by Padagis Us Llc on October 25, 2021.

    What is the NDC billing unit for package 0574-0930-10?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0574-0930-10?

    The 11-digit format is 00574093010. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20574-0930-105-4-200574-0930-10